Microrobots may become an effective tool in breaking down the dangerous blood vessel blockages that cause strokes. But these ...
As world leaders, investors, and innovators gather at COP30, the focus is shifting from promises to performance.
Combined capital will support the ongoing Phase 2a clinical trial of procizumab in cardiogenic shock Hennigsdorf/Berlin, November 13, 2025 – 4TEEN4 Pharmaceuticals GmbH (“4TEEN4”) today announced the ...
Action is needed locally, nationally, and internationally to curb sales of new sports utility vehicles (SUVs) to reduce their ...
Despite making up half of the 64 million people living with heart failure, patients with this common form have no access to ...
BY GBENGA AYINDE Every great power first conquered the imagination before it conquered the marketplace. Before Hollywood ...
Health professionals must support the health and environmental case for policy actionAction is needed locally, nationally, ...
A research team has developed a causal deep learning model to personalize corticosteroid therapy for intensive care unit ...
When Abuja became Nigeria’s capital city many years ago, it was understandable that the city was not just the seat of power ...
Researchers in Switzerland are testing a new way to deliver lifesaving stroke medication — by steering microscopic gel ...